Cargando…

Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs)

Purpose: To model CML progression in vitro and generate a blast crisis (BC-CML) model in vitro in order to identify new targets. Methods: Three different CML-derived iPSC lines were mutagenized with the alkylating agent ENU on a daily basis for 60 days. Cells were analyzed at D12 of hematopoietic di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imeri, Jusuf, Desterke, Christophe, Marcoux, Paul, Telliam, Gladys, Sanekli, Safa, Barreau, Sylvain, Erbilgin, Yucel, Latsis, Theodoros, Hugues, Patricia, Sorel, Nathalie, Cayssials, Emilie, Chomel, Jean-Claude, Bennaceur-Griscelli, Annelise, Turhan, Ali G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953961/ https://www.ncbi.nlm.nih.gov/pubmed/36831265 http://dx.doi.org/10.3390/cells12040598

Ejemplares similares

Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs)
por: Telliam, Gladys, et al.
Publicado: (2023)

Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID‐19‐associated organ failure
por: Desterke, Christophe, et al.
Publicado: (2020)

iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
por: Turhan, Ali G., et al.
Publicado: (2021)

Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance
por: Imeri, Jusuf, et al.
Publicado: (2023)

ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia
por: Baykal, Seda, et al.
Publicado: (2023)

Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis
por: Boucher, Lara, et al.
Publicado: (2023)

Patient-Derived iPSCs Reveal Evidence of Telomere Instability and DNA Repair Deficiency in Coats Plus Syndrome
por: Oudrhiri, Noufissa, et al.
Publicado: (2022)

PPARγ Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19
por: Desterke, Christophe, et al.
Publicado: (2020)

HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease
por: Desterke, Christophe, et al.
Publicado: (2021)

EGR1 dysregulation defines an inflammatory and leukemic program in cell trajectory of human-aged hematopoietic stem cells (HSC)
por: Desterke, Christophe, et al.
Publicado: (2021)

iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression
por: Portier, Lucie, et al.
Publicado: (2021)

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)
por: Gentil, Melanie, et al.
Publicado: (2018)

iPSC-Derived Embryoid Bodies as Models of c-Met-Mutated Hereditary Papillary Renal Cell Carcinoma
por: Hwang, Jin Wook, et al.
Publicado: (2019)

Detection of Hematopoietic Stem Cell Transcriptome in Human Fetal Kidneys and Kidney Organoids Derived From Human Induced Pluripotent Stem Cells
por: Hwang, Jin Wook, et al.
Publicado: (2021)

Global MicroRNA Profiling Uncovers miR-206 as a Negative Regulator of Hematopoietic Commitment in Human Pluripotent Stem Cells
por: Flamant, Stéphane, et al.
Publicado: (2019)

Embryonic Program Activated during Blast Crisis of Chronic Myelogenous Leukemia (CML) Implicates a TCF7L2 and MYC Cooperative Chromatin Binding
por: Desterke, Christophe, et al.
Publicado: (2020)

Genomic landscape analyses of reprogrammed cells using integrative and non-integrative methods reveal variable cancer-associated alterations
por: Griscelli, Frank, et al.
Publicado: (2019)

Evidence of Antitumor and Antimetastatic Potential of Induced Pluripotent Stem Cell-Based Vaccines in Cancer Immunotherapy
por: Kishi, Masae, et al.
Publicado: (2021)

Modeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitors
por: Aggoune, Djamel, et al.
Publicado: (2014)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation
por: Chomel, Jean Claude, et al.
Publicado: (2016)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

Clinically silent indolent T‐cell leukemia
por: Janot, Clément, et al.
Publicado: (2018)

A mesenchymal glioma stem cell profile is related to clinical outcome
por: Balbous, A, et al.
Publicado: (2014)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Differentiation of human iPSCs into functional podocytes
por: Rauch, Caroline, et al.
Publicado: (2018)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

Disease, iPSCs and a Quest for the Perfect Model
Publicado: (2016)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
por: Compagnucci, Claudia, et al.
Publicado: (2017)

The tale of autologous iPSCs: A monkey perspective
por: Li, Fei
Publicado: (2014)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Functional genomics and the future of iPSCs in disease modeling
por: Brooks, Imogen R., et al.
Publicado: (2022)

Modelling urea cycle disorders using iPSCs
por: Duff, Claire, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7iiraelhu8fdftiv1j7mtpigd4